FDA Clearance Tracker · DEN250040
SportSuite Vision Software
Last checked: Nov 19, 2026Latest source record: Jul 17, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 17, 2026
De Novo granted
Time to decision
318 days
Received Sep 2, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN250040
- Device name
- SportSuite Vision Software
- Applicant
- Stryker Endoscopy
- Applicant location
- San Jose, CA
- Received
- Sep 2, 2025
- Decided
- Jul 17, 2026
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.1150
- Specialty
- Orthopedic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN250040
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Stryker Endoscopy
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262369 · Decided Jul 30, 2026 · 20 days after receipt
Device type: Fastener, Fixation, Nondegradable, Soft Tissue (MBI) · Orthopedic Surgery
- Precision S 4K Sinuscope510(k)
K253602 · Decided Jun 4, 2026 · 198 days after receipt
Device type: Endoscope, Neurological (GWG) · Neurology & Neurosurgery
K261037 · Decided May 28, 2026 · 59 days after receipt
Device type: System, X-Ray, Angiographic (IZI) · Radiology & Imaging
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.